{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:43:57Z","timestamp":1775173437214,"version":"3.50.1"},"reference-count":246,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1053\/j.arrt.2004.04.010","type":"journal-article","created":{"date-parts":[[2006,1,9]],"date-time":"2006-01-09T16:13:30Z","timestamp":1136823210000},"page":"274-293","source":"Crossref","is-referenced-by-count":9,"title":["Impact of kidney transplantation on the progression of cardiovascular disease"],"prefix":"10.1053","volume":"11","author":[{"given":"Sangeetha","family":"Satyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie L","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.arrt.2004.04.010_BIB1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.281.8.727","article-title":"Prevalence and extent of atherosclerosis in adolescents and young adults","volume":"281","author":"Strong","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/0735-1097(94)90141-4","article-title":"Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction","volume":"24","author":"Celermajer","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The Pathogenesis of atherosclerosis","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1053\/j.arrt.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/01.ATV.19.6.1491","article-title":"The natural course of atherosclerosis: Part II: Vascular remodeling","volume":"19","author":"Kiechl","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(01)01374-2","article-title":"Arterial remodeling and coronary artery disease","volume":"38","author":"Schoenhagen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Mechanisms of disease","volume":"340","author":"Ross","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB10","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB11","series-title":"USRDS Annual Data Report 2003","year":"2003"},{"key":"10.1053\/j.arrt.2004.04.010_BIB12","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/00007890-200206270-00013","article-title":"The changing causes of graft loss and death after kidney transplantation","volume":"73","author":"Howard","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1681\/ASN.V1261293","article-title":"Survival improvement among patients with end-stage renal disease","volume":"12","author":"Meier-Kriesche","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB14","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0041-1345(98)00531-4","article-title":"Cardiovascular complications after renal transplantation","volume":"30","author":"Aker","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","article-title":"Cardiovascular morbidity and risk factors in renal transplant patients","volume":"14","author":"Aakhus","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0002-9343(88)90302-6","article-title":"Risk factors for accelerated atherosclerosis in renal transplant recipients","volume":"84","author":"Kasiske","year":"1988","journal-title":"Am J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1986.00520020007006","article-title":"Stroke in renal transplant recipients","volume":"43","author":"Adams","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00007890-200010150-00010","article-title":"Peripheral vascular occlusive disease in renal transplant recipients","volume":"70","author":"Sung","year":"2000","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2003.02042.x","article-title":"Stroke in renal transplant recipients","volume":"17","author":"Oliveras","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB23","series-title":"Heart Disease and Stroke Statistics\u20142003 Update. American Heart Association","year":"2003"},{"key":"10.1053\/j.arrt.2004.04.010_BIB24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB27","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary artery disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB29","doi-asserted-by":"crossref","first-page":"49U","DOI":"10.1016\/S0002-9149(98)00953-9","article-title":"Triglycerides as a risk factor for coronary artery disease","volume":"82","author":"Dennis","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease","volume":"290","author":"Hackam","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB32","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0041-1345(01)02150-9","article-title":"Evaluation of serum levels of lipids and lipoproteins in kidney-transplanted patients","volume":"33","author":"Mortazavi","year":"2001","journal-title":"Transplant Proc"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB33","first-page":"S142","article-title":"Hyperlipidemia in patients with chronic renal disease","volume":"32","author":"Bertram","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid organ transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"issue":"suppl 15","key":"10.1053\/j.arrt.2004.04.010_BIB35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00007890-199001000-00013","article-title":"The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation","volume":"49","author":"Moore","year":"1990","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB37","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB38","series-title":"K\/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease","year":"2004"},{"key":"10.1053\/j.arrt.2004.04.010_BIB39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1034\/j.1399-0012.1999.130613.x","article-title":"A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients","volume":"13","author":"Lepre","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0735-1097(92)90340-S","article-title":"Hyperlipidemia after heart transplantation","volume":"19","author":"Ballantyne","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0041-1345(01)02813-5","article-title":"Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients","volume":"34","author":"Cofan","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB42","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB43","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB45","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pu.08.050187.001345","article-title":"Physical activity and the incidence of coronary heart disease","volume":"8","author":"Powell","year":"1987","journal-title":"Annu Rev Public Health"},{"key":"10.1053\/j.arrt.2004.04.010_BIB47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/oxfordjournals.aje.a117386","article-title":"Prospective study of intentional weight-loss and mortality in never-smoking overweight US white women aged 40\u201364","volume":"141","author":"Williamson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB48","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.258.17.2388","article-title":"Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial","volume":"258","author":"Leon","year":"1987","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB49","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/hc3901.095960","article-title":"Exercise standards for testing and training","volume":"104","author":"Fletcher","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB50","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.94.4.857","volume":"94","author":"Fletcher","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB51","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jama.281.18.1722","article-title":"Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease","volume":"281","author":"Smith","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/ajkd.2003.50059","article-title":"Demographics and trends in overweight and obesity in patients at time of kidney transplantation","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB53","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ndt\/16.5.1047","article-title":"Metabolic cardiovascular syndrome after renal transplantation","volume":"16","author":"Hjelmasaeth","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0899-9007(01)00723-7","article-title":"Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients","volume":"18","author":"Baum","year":"2002","journal-title":"Nutrition"},{"key":"10.1053\/j.arrt.2004.04.010_BIB55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/ajkd.2001.26100","article-title":"Variables affecting weight gain in renal transplant recipients","volume":"38","author":"Clunk","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB56","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00007890-199310000-00008","article-title":"Factors influencing weight gain after renal transplantation","volume":"56","author":"Johnson","year":"1993","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB57","first-page":"21","article-title":"Hyperlipidemia and obesity after renal transplantation","volume":"6","author":"Teplan","year":"2001","journal-title":"Ann Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-199708270-00009","article-title":"Should obese patients lose weight before receiving a kidney transplant?","volume":"64","author":"Modlin","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00007890-200209150-00003","article-title":"Obesity and transplantation","volume":"74","author":"Jurewicz","year":"2002","journal-title":"Transplantation 2002"},{"key":"10.1053\/j.arrt.2004.04.010_BIB60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1432-2277.1997.tb00705.x","article-title":"Is obesity still a risk factor in renal transplantation?","volume":"10","author":"Halme","year":"1997","journal-title":"Transpl Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB61","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00007890-199911150-00013","article-title":"The effect of body mass index on long-term renal allograft survival","volume":"68","author":"Meier-Kriesche","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0899-9007(98)00137-3","article-title":"Benefits of a dietary intervention on weight loss, body composition, and lipid profile after renal transplantation","volume":"15","author":"Lopes","year":"1999","journal-title":"Nutrition"},{"key":"10.1053\/j.arrt.2004.04.010_BIB63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1051-2276(98)90005-X","article-title":"The effect of dietary intervention on weight gains after renal transplantation","volume":"8","author":"Patel","year":"1998","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.arrt.2004.04.010_BIB64","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB65","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.HYP.35.2.539","article-title":"Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification","volume":"35","author":"Ogden","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/j.arrt.2004.04.010_BIB67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"issue":"8 suppl","key":"10.1053\/j.arrt.2004.04.010_BIB68","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.V48s30","article-title":"Hypertension after renal transplantation","volume":"4","author":"First","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000045184","article-title":"Hypertension in the transplanted patient","volume":"80","author":"Zeier","year":"1998","journal-title":"Nephron"},{"key":"10.1053\/j.arrt.2004.04.010_BIB70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70253-2","article-title":"Early immunologic and nonimmunologic predictors of arterial hypertension after renal transplantation","volume":"33","author":"Perez Fontan","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/trre.2002.28890","article-title":"Cardiovascular risk associated with immunosuppression in renal transplantation","volume":"16","author":"Kasiske","year":"2002","journal-title":"Transplant Rev"},{"key":"10.1053\/j.arrt.2004.04.010_BIB72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1681\/ASN.V781131","article-title":"Hypertension may be transplanted with the kidney in humans","volume":"7","author":"Guidi","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB73","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0090-4295(94)90157-0","article-title":"Laparoscopic bilateral nephrectomy for renin-mediated hypertension","volume":"43","author":"Bales","year":"1994","journal-title":"Urology"},{"key":"10.1053\/j.arrt.2004.04.010_BIB74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00007890-198808000-00009","article-title":"Antihypertensive effect of beta-blockade in renal transplant recipients with or without host kidneys","volume":"46","author":"Huysmans","year":"1988","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB75","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB76","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.V9112096","article-title":"Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition and blood pressure control on chronic non-diabetic nephropathies","volume":"9","author":"Ruggenenti","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB77","doi-asserted-by":"crossref","first-page":"110S","DOI":"10.1002\/j.1875-9114.1991.tb02640.x","article-title":"Management of drug interactions with cyclosporine","volume":"11","author":"Lake","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.arrt.2004.04.010_BIB78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin 2 antagonists in renal transplantation","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.HYP.26.3.436","article-title":"Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients","volume":"26","author":"Sennesael","year":"1995","journal-title":"Hypertension"},{"key":"10.1053\/j.arrt.2004.04.010_BIB80","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.HYP.33.3.862","article-title":"ACE inhibitor versus \u03b2-blocker for the treatment of hypertension in renal allograft recipients","volume":"33","author":"Hausberg","year":"1999","journal-title":"Hypertension"},{"key":"10.1053\/j.arrt.2004.04.010_BIB81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-199803150-00010","article-title":"Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy","volume":"65","author":"Mourad","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB82","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000061606.64917.BE","article-title":"A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation","volume":"75","author":"Pascual","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB83","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/01.ASN.0000071515.27754.67","article-title":"Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus","volume":"14","author":"Artz","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/ajkd.1998.v31.pm9428466","article-title":"Renal artery stenosis in kidney transplants","volume":"31","author":"Fervenza","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB87","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/00007890-199805150-00007","article-title":"Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy?","volume":"65","author":"Fricke","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB88","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/hc3001.093434","article-title":"Improvement in hypertension in patients with diabetes mellitus after kidney\/pancreas transplantation","volume":"104","author":"Elliott","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB89","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1053\/j.arrt.2004.04.010_BIB91","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","article-title":"Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure","volume":"343","author":"Makita","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB92","first-page":"273","article-title":"Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation","volume":"49","author":"Yoshida","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB93","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB94","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/ndt\/12.8.1672","article-title":"Patient survival after renal transplantation; more than 25 years follow-up","volume":"12","author":"Arend","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB95","first-page":"433","article-title":"Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients","volume":"7","author":"Rischen-Vos","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB96","first-page":"917","article-title":"Long-term follow-up of renal transplantation in type 1 and type 2 diabetic patients","volume":"70","author":"Hirsch","year":"1992","journal-title":"Clin Invest"},{"key":"10.1053\/j.arrt.2004.04.010_BIB97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-0012.1992.tb00128.x","article-title":"A case control study of renal transplantation in patients with type 1 diabetes","volume":"6","author":"Munson","year":"1992","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB98","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ndt\/5.3.220","article-title":"Post-transplant diabetes mellitus in renal allograft recipients","volume":"5","author":"von Kiparski","year":"1990","journal-title":"Nephrol Dial Transplant"},{"issue":"11 suppl","key":"10.1053\/j.arrt.2004.04.010_BIB99","first-page":"SS58","article-title":"Impact and management of posttransplant diabetes mellitus","volume":"70","author":"Jindal","year":"2000","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Posttransplantation diabetes","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1053\/j.arrt.2004.04.010_BIB101","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0041-1345(03)00052-6","article-title":"Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients","volume":"35","author":"Fernandez-Fresnedo","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB102","doi-asserted-by":"crossref","first-page":"SS3","DOI":"10.1097\/01.TP.0000069952.49242.3E","article-title":"New-onset diabetes after transplantation","volume":"75","author":"Davidson","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB103","unstructured":"World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Available at http:\/\/www.nzgg.org.nz\/library\/gl_complete\/diabetes\/who_report_diabetes_diagnosis-.pdf"},{"issue":"suppl 1","key":"10.1053\/j.arrt.2004.04.010_BIB104","first-page":"S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1053\/j.arrt.2004.04.010_BIB105","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0041-1345(01)02232-1","article-title":"Strategies for risk reduction and management of posttransplant diabetes mellitus","volume":"33","author":"Marchetti","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB106","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/diabetes.48.2.383","article-title":"Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications","volume":"48","year":"1999","journal-title":"Diabetes"},{"key":"10.1053\/j.arrt.2004.04.010_BIB108","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB109","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35)","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB111","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood pressure. The JNC 7 report","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB112","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.317.7160.693","article-title":"Combined high blood pressure and glucose in type 2 diabetes","volume":"317","author":"Mogensen","year":"1998","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB113","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB114","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.ASN.0000037678.54984.41","article-title":"Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas\/kidney transplants","volume":"14","author":"Bunnapradist","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0041-1345(00)02635-X","article-title":"Long-term benefit of kidney-pancreas transplants in type 1 diabetics","volume":"33","author":"Ojo","year":"2001","journal-title":"Transplant Proceed"},{"key":"10.1053\/j.arrt.2004.04.010_BIB116","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/01.TP.0000061788.32639.D9","article-title":"Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation","volume":"75","author":"Fiorina","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB117","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.2337\/diabetes.50.3.496","article-title":"Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes","volume":"50","author":"Fiorina","year":"2001","journal-title":"Diabetes"},{"key":"10.1053\/j.arrt.2004.04.010_BIB118","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0272-6386(97)90344-9","article-title":"Atherosclerotic vascular complications in diabetic transplant candidates","volume":"29","author":"Manske","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB119","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0140-6736(92)93010-K","article-title":"Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure","volume":"40","author":"Manske","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB120","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ndt\/12.6.1187","article-title":"Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy","volume":"12","author":"Koch","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB121","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0009-9120(03)00062-6","article-title":"Hyperhomocysteinemia and its role in the development of atherosclerosis","volume":"36","author":"Lawrence de Koning","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1053\/j.arrt.2004.04.010_BIB122","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB123","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB124","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB125","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa011364","article-title":"Decreased rate of coronary restenosis after lowering of plasma homocysteine levels","volume":"345","author":"Schnyder","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V111134","article-title":"Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients","volume":"11","author":"Ducloux","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","article-title":"Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients","volume":"61","author":"Arnadottir","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB128","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/ndt\/13.11.2890","article-title":"Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients","volume":"13","author":"Ducloux","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB129","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1161\/01.ATV.19.12.2918","article-title":"Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients","volume":"19","author":"Beaulieu","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB130","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.7326\/0003-4819-127-12-199712150-00006","article-title":"Treatment of hyperhomocysteinemia in renal transplant recipients","volume":"127","author":"Bostom","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB131","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/01.TP.0000058810.59825.58","article-title":"Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients","volume":"75","author":"Marcucci","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB132","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.282.22.2149","article-title":"Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol","volume":"282","author":"Jee","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB133","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/euhj.2000.2151","article-title":"Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men","volume":"21","author":"Qiao","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1053\/j.arrt.2004.04.010_BIB134","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archinte.160.7.939","article-title":"Effect of smoking cessation on mortality after myocardial infarction","volume":"160","author":"Wilson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.269.2.232","article-title":"Smoking cessation and the decreased risk of stroke in women","volume":"269","author":"Kawachi","year":"1993","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB136","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.281.1.72","article-title":"Recent advances in the pharmacotherapy of smoking","volume":"281","author":"Hughes","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(94)90933-4","article-title":"Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation","volume":"343","author":"Silagy","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB138","series-title":"Smoking cessation","year":"1996"},{"key":"10.1053\/j.arrt.2004.04.010_BIB139","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1681\/ASN.V114753","article-title":"Cigarette smoking in renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1399-0012.1999.130410.x","article-title":"Patient survival after renal transplantation: II. The impact of smoking","volume":"13","author":"Cosio","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB141","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00007890-200002270-00019","article-title":"Progression of macrovascular disease after transplantation","volume":"69","author":"Nankivell","year":"2000","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB142","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB143","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB144","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease","volume":"290","author":"Hackam","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB146","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11883-003-0004-3","article-title":"C-reactive protein and risk of cardiovascular disease","volume":"5","author":"Ridker","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"10.1053\/j.arrt.2004.04.010_BIB147","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/ajkd.2002.32794","article-title":"Pre-transplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients","volume":"39","author":"Fink","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB148","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-8981(01)00523-X","article-title":"Do serum C-reactive protein measurements help to discriminate episodes of renal dysfunction in patients after renal transplantation?","volume":"310","author":"Reek","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.arrt.2004.04.010_BIB149","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","article-title":"Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease","volume":"70","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB150","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00007890-200110270-00011","article-title":"Cytomegalovirus disease is not a major risk factor for ischemic heart disease after renal transplantation","volume":"72","author":"Hernandez","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB151","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-6143.2003.30114.x","article-title":"Determinants of cardiovascular mortality after renal transplantation","volume":"3","author":"Kalil","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB152","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/003655102321004512","article-title":"Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls","volume":"62","author":"Muller","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1053\/j.arrt.2004.04.010_BIB153","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.CIR.0000021125.83697.21","article-title":"Predisposition to atherosclerosis by infections","volume":"106","author":"Prasad","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB154","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0735-1097(96)00055-1","article-title":"Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease","volume":"27","author":"Muhlestein","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB155","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.97.17.1675","article-title":"Association of virulent Helicobacter pylori strains with ischemic heart disease","volume":"97","author":"Pasceri","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB156","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.0000044940.65226.1F","article-title":"Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"107","author":"Smieja","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB157","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.160.13.2027","article-title":"A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease","volume":"160","author":"Sorlie","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1086\/517355","article-title":"Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis","volume":"177","author":"Adler","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB159","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.102.16.1917","article-title":"Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease","volume":"102","author":"Muhlestein","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB160","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/01.CIR.0000056032.56396.89","article-title":"Antibiotic treatment of atherosclerotic cardiovascular disease","volume":"107","author":"Grayston","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB161","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","article-title":"Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: A randomized controlled trial","volume":"290","author":"O\u2019Connor","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB162","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ki.1983.86","article-title":"Postrenal transplant erythrocytosis","volume":"23","author":"Wickre","year":"1983","journal-title":"Kidney Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB163","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera","volume":"123","author":"Gruppo","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB164","first-page":"45","article-title":"Hemorrhagic and thrombotic complications in polycythemia vera","volume":"74","author":"Orlandi","year":"1989","journal-title":"Hematolgia"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB165","first-page":"47","article-title":"Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors","volume":"53","author":"Montanaro","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB166","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1681\/ASN.V961104","article-title":"Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis","volume":"9","author":"Julian","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB167","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007890-200108150-00035","article-title":"Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients","volume":"72","author":"Yildiz","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB168","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","article-title":"A prospective study of fibrinogen and risk of myocardial infarction in the Physicians\u2019 Health Study","volume":"33","author":"Ma","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB169","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0037-1615353","article-title":"Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction\u2014the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction","volume":"80","author":"Scarabin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.arrt.2004.04.010_BIB170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.258.9.1183","article-title":"Fibrinogen and risk of cardiovascular disease","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90062-Y","article-title":"The role of fibrinogen as a cardiovascular risk factor","volume":"100","author":"Ernst","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB172","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ndt\/12.1.167","article-title":"Environemental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients","volume":"12","author":"Irish","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB173","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ndt\/14.6.1525","article-title":"Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients","volume":"14","author":"Linde","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB174","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.ATV.19.6.1555","article-title":"Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients","volume":"19","author":"Van den Dorpel","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB175","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/01.TP.0000058544.71993.E6","article-title":"Plasma fibrinolytic capacity in renal transplant recipients","volume":"75","author":"Sartori","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB176","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00007890-199609270-00021","article-title":"The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients","volume":"62","author":"Malyszko","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB177","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1523-1755.2001.0590041574.x","article-title":"Determinants of enhanced thromboxane biosynthesis in renal transplantation","volume":"59","author":"Averna","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB178","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mcp.2002.127115","article-title":"Immunosuppressive therapy regimen and platelet activation in renal transplant patients","volume":"72","author":"Graff","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.arrt.2004.04.010_BIB179","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"Br Med J"},{"key":"10.1053\/j.arrt.2004.04.010_BIB180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB181","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diabetes.41.6.736","article-title":"Prospective study of microalbuminuria as predictor of mortality in NIDDM","volume":"41","author":"Mattock","year":"1992","journal-title":"Diabetes"},{"key":"10.1053\/j.arrt.2004.04.010_BIB182","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.arrt.2004.04.010_BIB183","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB184","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB185","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.STR.27.11.2033","article-title":"Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic patients","volume":"27","author":"Miettinen","year":"1996","journal-title":"Stroke"},{"key":"10.1053\/j.arrt.2004.04.010_BIB186","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00007890-200204270-00028","article-title":"The risk of cardiovascular disease associated with proteinuria in renal transplant patients","volume":"73","author":"Fernandez-Fresnedo","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB187","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0041-1345(00)02447-7","article-title":"Proteinuria and death risk in renal transplant population","volume":"33","author":"Roodnat","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB188","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.ASN.0000051594.21922.99","article-title":"Development of renal disease in people at high cardiovascular risk","volume":"14","author":"Mann","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB189","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","article-title":"Prognostic significance of renal function in elderly patients with isolated systolic hypertension","volume":"13","author":"De Leeuw","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.arrt.2004.04.010_BIB191","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB192","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.TP.0000061602.03327.E2","article-title":"Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB193","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1034\/j.1600-6143.2002.21015.x","article-title":"Death after graft loss","volume":"2","author":"Kaplan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB194","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1046\/j.1523-1755.2002.00611.x","article-title":"Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients","volume":"62","author":"Lemieux","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB195","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0041-1345(02)03082-8","article-title":"Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids","volume":"34","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB196","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB197","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/16.4.829","article-title":"Tapering off prednisolone and cyclosporin the first year after renal transplantation","volume":"16","author":"Hjelmasaeth","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB198","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00007890-200212270-00011","article-title":"Early steroid withdrawal in renal transplantation with tacrolimus dual therapy","volume":"74","author":"Boots","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB199","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0041-1345(01)02846-9","article-title":"Steroid withdrawal after renal transplantation-risks and benefits","volume":"34","author":"Nowacka-Cieciura","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB200","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0272-6386(12)80355-6","article-title":"The adverse impact of cyclosporine on serum lipids in renal transplant recipients","volume":"6","author":"Kasiske","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.arrt.2004.04.010_BIB201","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007890-199409000-00005","article-title":"Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients","volume":"58","author":"Apanay","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0012.1997.tb00810.x","article-title":"Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients","volume":"11","author":"Hohage","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007890-199802150-00030","article-title":"Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine","volume":"65","author":"Satterthwaite","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-199801150-00017","article-title":"Effects of tacrolimus on hyperlipidemia after successful renal transplantation","volume":"65","author":"McCune","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB205","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0041-1345(02)03083-X","article-title":"Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients","volume":"34","author":"Boucher","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/oxfordjournals.ndt.a027761","article-title":"Cyclosporin A-associated hypertension\u2014pathomechanisms and clinical consequences","volume":"12","author":"Haas","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB207","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB208","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2165\/00003495-200363150-00002","article-title":"Calcineurin inhibitors in renal transplantation. What is the best option?","volume":"63","author":"Tanabe","year":"2003","journal-title":"Drugs"},{"key":"10.1053\/j.arrt.2004.04.010_BIB209","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.arrt.2004.04.010_BIB210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0002-9610(02)00826-7","article-title":"Immunosuppression impact on long-term cardiovascular complications after liver transplantation","volume":"183","author":"Rabkin","year":"2002","journal-title":"Am J Surg"},{"key":"10.1053\/j.arrt.2004.04.010_BIB211","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","article-title":"A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation","volume":"73","author":"Vincenti","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB212","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00007890-200203150-00012","article-title":"Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects","volume":"73","author":"Klein","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB213","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0041-1345(02)02859-2","article-title":"Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients","volume":"34","author":"Colak","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB214","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0041-1345(02)03080-4","article-title":"Randomized conversion from cyclosporine to tacrolimus in renal transplant patients","volume":"34","author":"Artz","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.TP.0000074310.40484.94","article-title":"Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen","volume":"76","author":"Chueh","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB216","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.V122368","article-title":"Cardiovascular risk factors in renal transplant patients","volume":"12","author":"Ligtenberg","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB217","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","article-title":"Hyperhomocysteinemia in cyclosporine -treated renal transplant recipients","volume":"61","author":"Arnadottir","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB218","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0041-1345(03)00052-6","article-title":"Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients","volume":"35","author":"Fernandez-Fresnedo","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB219","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00007890-200202150-00011","article-title":"Diabetes mellitus in kidney allograft recipients","volume":"73","author":"First","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0012.1997.tb00810.x","article-title":"Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients","volume":"11","author":"Hohage","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1053\/j.arrt.2004.04.010_BIB221","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199409000-00006","article-title":"The effect of FK506 versus cyclosporine on glucose and lipid metabolism\u2014a randomized trial","volume":"58","author":"Steinmuller","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB222","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus vs. cyclosporine for immunosuppression in renal transplantation","volume":"318","author":"Knoll","year":"1999","journal-title":"BMJ"},{"key":"10.1053\/j.arrt.2004.04.010_BIB223","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB224","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/00007890-200111270-00014","article-title":"Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients","volume":"72","author":"Maes","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB225","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1046\/j.1523-1755.1998.00112.x","article-title":"Serum total homocysteine concentration before and after renal transplantation","volume":"54","author":"Arnadottir","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.arrt.2004.04.010_BIB226","first-page":"232","article-title":"Hyperhomocysteinemia in renal transplant recipients with and without cyclosporine","volume":"49","author":"Ducloux","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00007890-199907270-00017","article-title":"Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients","volume":"68","author":"Bostom","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB228","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0041-1345(02)02971-8","article-title":"Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy","volume":"34","author":"Wayman","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB229","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007890-200107270-00014","article-title":"Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation","volume":"72","author":"Ahsan","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/00007890-200110270-00009","article-title":"Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients","volume":"72","author":"Ovuworie","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB231","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/00007890-200212270-00015","article-title":"Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients","volume":"12","author":"Abramowicz","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB232","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000061606.64917.BE","article-title":"A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation","volume":"75","author":"Pascual","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB233","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.TP.0000074310.40484.94","article-title":"Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen","volume":"76","author":"Chueh","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB234","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB235","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/01.TP.0000062837.99400.60","article-title":"Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1053\/j.arrt.2004.04.010_BIB236","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1016\/S0041-1345(03)00241-0","article-title":"Cardiovascular risk factors of sirolimus compared with cyclosporine","volume":"35","author":"Legendre","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1053\/j.arrt.2004.04.010_BIB237","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB238","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients","volume":"13","author":"Rigatto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB239","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.TP.0000084872.26360.C5","article-title":"Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients","volume":"76","author":"Djamali","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB240","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.ASN.0000083008.25305.67","article-title":"Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression","volume":"14","author":"Abbott","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB241","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1047-2797(01)00272-1","article-title":"Hospitalized congestive heart failure after renal transplantation in the United States","volume":"12","author":"Abbott","year":"2002","journal-title":"Ann Epidemiol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB242","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00007890-199511150-00005","article-title":"Impact of renal transplantation on uremic cardiomyopathy","volume":"60","author":"Parfrey","year":"1995","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB243","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007890-200008270-00006","article-title":"Long-term changes in left ventricular hypertrophy after renal transplantation","volume":"70","author":"Rigatto","year":"2000","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB244","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/00007890-200212150-00016","article-title":"Cardiovascular effects of successful renal transplantation","volume":"74","author":"Ferreira","year":"2002","journal-title":"Transplantation"},{"key":"10.1053\/j.arrt.2004.04.010_BIB245","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients","volume":"14","author":"Rigatto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.arrt.2004.04.010_BIB246","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559504000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559504000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:16:50Z","timestamp":1736209010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559504000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":246,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1548559504000795"],"URL":"https:\/\/doi.org\/10.1053\/j.arrt.2004.04.010","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}